$HRGN
Harvard Apparatus Regenerative Technology Inc Stock $hrgn

$hrgn Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000114420414018938 Filed on March 31, 2014

Income Statement

Concept	2014 Q1	2012 Q4	2012 Q3
Revenue	$23.00K	$0.00	$0.00
YoY Change
Cost Of Revenue	$12.00K	$0.00	$0.00
YoY Change
Gross Profit	$11.00K	$0.00	$0.00
YoY Change
Gross Profit Margin	47.83%
Selling, General & Admin	$1.800M	$960.0K	$669.0K
YoY Change	109.3%	47.69%
% of Gross Profit	16363.64%
Research & Development	$1.217M	$1.000M	$1.059M
YoY Change	4.91%	63.93%
% of Gross Profit	11063.64%
Depreciation & Amortization	$56.00K	$20.00K	$40.00K
YoY Change	47.37%	100.0%	300.0%
% of Gross Profit	509.09%
Operating Expenses	$3.017M	$1.966M	$1.728M
YoY Change	49.36%	57.28%
Operating Profit	-$3.006M	-$1.966M	-$1.728M
YoY Change	48.81%	57.28%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00
YoY Change
Pretax Income	-$3.006M	-$1.970M
YoY Change	48.81%	57.6%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.006M	-$1.970M	-$1.728M
YoY Change	48.81%	57.6%
Net Earnings / Revenue	-13069.57%
Basic Earnings Per Share
Diluted Earnings Per Share	-$7.718M	-$5.051M
COMMON SHARES
Basic Shares Outstanding	7.803M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2012 Q4	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.61M	$0.00	$0.00
YoY Change
Cash & Equivalents	$12.61M	$0.00
Short-Term Investments
Other Short-Term Assets	$350.0K
YoY Change
Inventory	$129.0K	$0.00	$0.00
Prepaid Expenses	$349.0K	$0.00
Receivables		$0.00	$0.00
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$13.10M	$0.00	$0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$760.0K	$438.0K	$300.0K
YoY Change		130.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$760.0K	$438.0K	$300.0K
YoY Change		130.53%
TOTAL ASSETS
Total Short-Term Assets	$13.10M	$0.00	$0.00
Total Long-Term Assets	$760.0K	$438.0K	$300.0K
Total Assets	$13.86M	$438.0K	$300.0K
YoY Change		130.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$410.0K	$179.0K	$20.00K
YoY Change		258.0%
Accrued Expenses	$300.0K	$230.0K	$130.0K
YoY Change		91.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$870.0K	$411.0K	$160.0K
YoY Change		141.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$870.0K	$411.0K	$160.0K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$870.0K	$411.0K	$160.0K
YoY Change		141.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.980M	$0.00
YoY Change
Common Stock		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.99M	$27.00K	$140.0K
YoY Change
Total Liabilities & Shareholders Equity	$13.86M	$438.0K	$300.0K
YoY Change		130.53%

Cashflow Statement

Concept	2014 Q1	2012 Q4	2012 Q3
OPERATING ACTIVITIES
Net Income	-$3.006M	-$1.970M	-$1.728M
YoY Change	48.81%	57.6%
Depreciation, Depletion And Amortization	$56.00K	$20.00K	$40.00K
YoY Change	47.37%	100.0%	300.0%
Cash From Operating Activities	-$1.410M	-$1.530M	-$4.370M
YoY Change	-26.94%	23.39%	87.55%
INVESTING ACTIVITIES
Capital Expenditures	$242.0K	-$160.0K	-$150.0K
YoY Change	1244.44%	77.78%	25.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$240.0K	-$160.0K	-$150.0K
YoY Change	1100.0%	77.78%	25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$247.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	250.0K	1.690M	4.520M
YoY Change	-87.18%	27.07%	84.49%
NET CHANGE
Cash From Operating Activities	-1.410M	-1.530M	-4.370M
Cash From Investing Activities	-240.0K	-160.0K	-150.0K
Cash From Financing Activities	250.0K	1.690M	4.520M
Net Change In Cash	-1.400M	0.000	0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$1.410M	-$1.530M	-$4.370M
Capital Expenditures	$242.0K	-$160.0K	-$150.0K
Free Cash Flow	-$1.652M	-$1.370M	-$4.220M
YoY Change	-15.2%	19.13%	90.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1974000	USD
CY2013	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	15000000	USD
CY2012	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1100000	USD
CY2013	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	2000000	USD
CY2012Q4	us-gaap	Cash Cash	0	USD
CY2013Q4	us-gaap	Cash Cash	14008000	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	0	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	421000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	0	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	14489000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	438000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	575000	USD
CY2012Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	438000	USD
CY2013Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	575000	USD
CY2012Q4	us-gaap	Assets Assets	438000	USD
CY2013Q4	us-gaap	Assets Assets	15064000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	179000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	244000	USD
CY2012Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	232000	USD
CY2013Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	161000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	411000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	495000	USD
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	USD
CY2012Q4	us-gaap	Liabilities Liabilities	411000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	495000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	USD
CY2012	us-gaap	Revenues Revenues	0	USD
CY2013	us-gaap	Revenues Revenues	22000	USD
	us-gaap	Revenues Revenues	22000	USD
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	11000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	11000	USD
CY2012	us-gaap	Gross Profit GrossProfit	0	USD
CY2013	us-gaap	Gross Profit GrossProfit	11000	USD
	us-gaap	Gross Profit GrossProfit	11000	USD
CY2012	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	116000	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	259000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2570000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11995000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	8828000	USD
	us-gaap	Operating Expenses OperatingExpenses	21226000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-6713000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-8817000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21215000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-6713000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-8817000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-21215000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	511000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	1370000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2278000	USD
CY2012	us-gaap	Depreciation Depreciation	59000	USD
CY2013	us-gaap	Depreciation Depreciation	158000	USD
	us-gaap	Depreciation Depreciation	238000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	116000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-71000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	161000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	310000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	295000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	813000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-310000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-295000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-813000	USD
CY2012	hart	Proceeds From Investment Made By Parent Company ProceedsFromInvestmentMadeByParentCompany	6207000	USD
CY2013	hart	Proceeds From Investment Made By Parent Company ProceedsFromInvestmentMadeByParentCompany	21986000	USD
	hart	Proceeds From Investment Made By Parent Company ProceedsFromInvestmentMadeByParentCompany	33503000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6207000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	21989000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	33506000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	0	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14008000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14008000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2009Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14008000	USD
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	38000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	421000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	130000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000	USD
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Trading Symbol TradingSymbol	HART
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7802573	shares
CY2013	dei	Entity Registrant Name EntityRegistrantName	Harvard Apparatus Regenerative Technology, Inc.
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001563665
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2012Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	0	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	22000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	38000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	0	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	77000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16466000	USD
CY2012Q4	hart	Investment By Parent Company InvestmentByParentCompany	27000	USD
CY2013Q4	hart	Investment By Parent Company InvestmentByParentCompany	0	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	27000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	14569000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	438000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15064000	USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	0	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7742080	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7742080	shares
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.87
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.74
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7740000	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7740000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7740000	shares
CY2012	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	0	USD
CY2013	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	22000	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	22000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	31000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	421000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	65000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	244000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	518000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	823000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	80000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	248000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5897000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7686000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-18685000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	22000	USD
CY2012	hart	Net Funds Provided By Parent Company NetFundsProvidedByParentCompany	6207000	USD
CY2013	hart	Net Funds Provided By Parent Company NetFundsProvidedByParentCompany	6228000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15758000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	USD
CY2013	hart	Shares Issued During Period Value Vesting Of Restricted Stock Units SharesIssuedDuringPeriodValueVestingOfRestrictedStockUnits	0	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> </td> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><b><i><font style="FONT-SIZE: 10pt">(b)</font></i></b></div> </td> <td style="WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="FONT-SIZE: 10pt"><b><i>Use of Estimates</i></b></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt">The process of preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates include, but are not limited to, stock-based compensation, accruals, depreciation and income taxes. Actual results could differ from those estimates and changes in estimates may occur.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013	hart	Percentage Of Revenue And Receivables From Related Parties PercentageOfRevenueAndReceivablesFromRelatedParties	1	pure
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	143000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	281000	USD
CY2012Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	265000	USD
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	388000	USD
CY2012Q4	hart	Computer Equipment And Software ComputerEquipmentAndSoftware	110000	USD
CY2013Q4	hart	Computer Equipment And Software ComputerEquipmentAndSoftware	154000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	93000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	32000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	125000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	57014	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	83606	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	31801	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	44776	USD
CY2013	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2017-05-31
CY2012Q1	us-gaap	Revenues Revenues	0	USD
CY2013Q1	us-gaap	Revenues Revenues	0	USD
CY2012Q2	us-gaap	Revenues Revenues	0	USD
CY2013Q2	us-gaap	Revenues Revenues	0	USD
CY2012Q3	us-gaap	Revenues Revenues	0	USD
CY2013Q3	us-gaap	Revenues Revenues	0	USD
CY2012Q4	us-gaap	Revenues Revenues	0	USD
CY2013Q4	us-gaap	Revenues Revenues	22000	USD
CY2012Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2012Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2012Q4	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	11000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	1728000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	2060000	USD
CY2012Q4	us-gaap	Operating Expenses OperatingExpenses	1966000	USD
CY2013Q4	us-gaap	Operating Expenses OperatingExpenses	2659000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1255000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2020000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1764000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2089000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1728000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2060000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1966000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2648000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-1255000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-2020000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-1764000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-2089000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-1728000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8602000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-339000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-215000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	18000	USD
CY2012	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	0	USD
CY2013	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	-50000	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2596000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	808000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-6374000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6713000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8817000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2013	hart	Percentage Of Option Lost Value Allocated To Parent Company Options PercentageOfOptionLostValueAllocatedToParentCompanyOptions	0.8	pure
CY2013	hart	Percentage Of Option Lost Value Allocated To Stock Options PercentageOfOptionLostValueAllocatedToStockOptions	0.2	pure
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2282000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2998000	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	40000	USD
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	13000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-402000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-118000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	48000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5037000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	808000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4828000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	514000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	209000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	294000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5037000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	808000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2013Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	90000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	0	USD
CY2013	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	90000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	90000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100	shares
CY2013Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	In March of 2013 the Company perfomed an 80,000 for 1 stock split to achive a desired 8 million shares outstanding.
CY2013Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	Immediately prior to the distribution on October 31, 2013 HART affected a reverse stock split so that shares outstanding became 7.7 millionto facilitate the 1 for 4 ratio for the Distribution. The distribution of the 7.7 million HART common shares to the shareholders of Harvard Bioscience is reflected as an issuance in the Consoluidated Statement of Stockholders Equity.
CY2013Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.2	pure
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85	pure
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	150000	shares
CY2013	hart	Income Tax Reconciliation Pre Separation Losses IncomeTaxReconciliationPreSeparationLosses	2327000	USD

Files In Submission

Name	View Source	Status
0001144204-14-018938-index-headers.html	Edgar Link	pending
0001144204-14-018938-index.html	Edgar Link	pending
0001144204-14-018938.txt	Edgar Link	pending
0001144204-14-018938-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hart-20131231.xml	Edgar Link	completed
hart-20131231.xsd	Edgar Link	pending
hart-20131231_cal.xml	Edgar Link	unprocessable
hart-20131231_def.xml	Edgar Link	unprocessable
hart-20131231_lab.xml	Edgar Link	unprocessable
hart-20131231_pre.xml	Edgar Link	unprocessable
line.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spacer.gif	Edgar Link	pending
v371822_10k.htm	Edgar Link	pending
v371822_ex21-1.htm	Edgar Link	pending
v371822_ex23-1.htm	Edgar Link	pending
v371822_ex31-1.htm	Edgar Link	pending
v371822_ex31-2.htm	Edgar Link	pending
v371822_ex32-1.htm	Edgar Link	pending
v371822_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HRGN
Harvard Apparatus Regenerative Technology Inc Stock $hrgn

2014 Q1 Form 10-K Financial Statement

#000114420414018938 Filed on March 31, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HRGN Harvard Apparatus Regenerative Technology Inc Stock $hrgn

2014 Q1 Form 10-K Financial Statement

#000114420414018938 Filed on March 31, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HRGN
Harvard Apparatus Regenerative Technology Inc Stock $hrgn